ACON News and Press, Aclarion Inc. From 01/29/24

2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion? PR Newswire NEW YORK , Jan. 29, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MDAI, AUVI, ADBE, BBAI, and ACON. To see how Inves...

2024-01-29 08:22:54 ET Losers: Panbela Therapeutics PBLA -63% on $9M public offering . Aclarion ( ACON ) -19% . Corbus Pharmaceuticals Holdings ( CRBP ) -21% it releases data for ADC Tumor candidate . Richtech Robotics ( RR ) -11% . ...

2024-01-26 12:32:20 ET Gainers: Corbus Pharmaceuticals Holdings ( CRBP ) +300% . Aclarion ( ACON ) +66% . Panbela Therapeutics ( PBLA ) +36% . Inspire Veterinary Partners ( IVP ) +36% . Rail Vision Ltd ( RVSN ) +34% . Appfoli...

2024-01-26 08:32:05 ET Losers: Aclarion ( ACON ) 119% . Panbela Therapeutics ( PBLA ) 59% . Processa Pharmaceuticals ( PCSA ) 29% . Corbus Pharmaceuticals Holdings ( CRBP ) 23% . as targeting antibody drug conjugate demonstrates encouragin...

2024-01-26 08:21:02 ET Aclarion ( ACON ) +113% . Panbela Therapeutics  ( PBLA ) +65% FORM S-1/A | Securities Registration Statement. TC BioPharm (Holdings)  ( TCBP ) +17% . Ucommune International  ( UK ) +17% . Processa Pharma...

2024-01-23 09:59:59 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-22 17:00:47 ET More on Aclarion, Inc. Financial information for Aclarion, Inc. Read the full article on Seeking Alpha For further details see: Aclarion files to sell 2.5M shares for its holder

Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice Chairman of Neurosurgery at Barrow Neurological Institute Dr. Uribe Becomes Aclarion’s 3 rd KOL With Access to a Diagnostic Center Authorized to Perform Nociscans BROO...

Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands accessibility of Nociscan on the worldwide MR market Builds on preexisting compatibility with Siemens BROOMFIELD, CO, Jan. 17, 2024 (GLOBE NE...